Pamela Ely

519 total citations
22 papers, 377 citations indexed

About

Pamela Ely is a scholar working on Hematology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pamela Ely has authored 22 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Genetics and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pamela Ely's work include Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Acute Myeloid Leukemia Research (5 papers). Pamela Ely is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Acute Myeloid Leukemia Research (5 papers). Pamela Ely collaborates with scholars based in United States, United Kingdom and Georgia. Pamela Ely's co-authors include Solveig G. Ericson, Paul M. Guyre, Jordan Dunitz, John Rogosheske, Wesley J. Miller, PM Guyre, MW Fanger, Letha E. Mills, Luying Pan and Daniel J. Weisdorf and has published in prestigious journals such as Blood, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Pamela Ely

21 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela Ely United States 10 139 100 99 85 70 22 377
A. Berer Austria 10 240 1.7× 91 0.9× 41 0.4× 76 0.9× 47 0.7× 13 448
Diahann T. S. L. Jansen Netherlands 13 190 1.4× 53 0.5× 70 0.7× 50 0.6× 69 1.0× 20 401
G. W. Löhr Germany 10 119 0.9× 90 0.9× 19 0.2× 46 0.5× 35 0.5× 18 386
B. Sean Carey United Kingdom 9 278 2.0× 39 0.4× 33 0.3× 79 0.9× 24 0.3× 20 507
Annunziata Manna Italy 10 138 1.0× 139 1.4× 36 0.4× 59 0.7× 25 0.4× 29 485
G. J. M. Lafeber Netherlands 15 199 1.4× 49 0.5× 31 0.3× 53 0.6× 100 1.4× 21 416
G Prentice Australia 7 85 0.6× 210 2.1× 70 0.7× 71 0.8× 11 0.2× 13 387
N. Amos United Kingdom 11 184 1.3× 54 0.5× 34 0.3× 53 0.6× 146 2.1× 15 403
Tommaso Stefanelli Italy 7 161 1.2× 259 2.6× 47 0.5× 63 0.7× 24 0.3× 24 490
S A Bell Germany 7 148 1.1× 43 0.4× 32 0.3× 52 0.6× 51 0.7× 8 312

Countries citing papers authored by Pamela Ely

Since Specialization
Citations

This map shows the geographic impact of Pamela Ely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Ely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Ely more than expected).

Fields of papers citing papers by Pamela Ely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Ely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Ely. The network helps show where Pamela Ely may publish in the future.

Co-authorship network of co-authors of Pamela Ely

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Ely. A scholar is included among the top collaborators of Pamela Ely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Ely. Pamela Ely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ely, Pamela. (2018). Is psoriasis a bowel disease? Successful treatment with bile acids and bioflavonoids suggests it is. Clinics in Dermatology. 36(3). 376–389. 27 indexed citations
2.
Meehan, Kenneth R., John M. Hill, Pamela Ely, et al.. (2007). Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplantation. 39(11). 695–703. 5 indexed citations
3.
4.
Meehan, Kenneth R., et al.. (2006). Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization. Transfusion. 46(4). 523–529. 19 indexed citations
5.
Porakishvili, Nino, Andrew P. Jewell, Pierre Youinou, et al.. (2005). Differential expression of CD180 and IgM by B‐cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes. British Journal of Haematology. 131(3). 313–319. 23 indexed citations
6.
Bubis, Jeffrey A., Pamela Ely, Kenneth R. Meehan, et al.. (2005). Pilot Study of Low Dose Melphalan and Bortezomib for Treatment of Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes.. Blood. 106(11). 4633–4633. 2 indexed citations
7.
Porakishvili, Nino, Andrew P. Jewell, Pierre Youinou, et al.. (2004). Differential Expression of CD180 and sIgM by B Chronic Lymphocytic Leukaemia Cells (B-CLL) Using Mutated and Unmutated IgVh Genes.. Blood. 104(11). 2807–2807. 3 indexed citations
8.
Siegel, Corey A., et al.. (2004). HEMOPHAGOCYTIC SYNDROME. The American Journal of Gastroenterology. 99. S134–S134. 2 indexed citations
9.
Park, Jonathan P., et al.. (2000). Amplification of the MLL Region in Acute Myeloid Leukemia. Cancer Genetics and Cytogenetics. 121(2). 198–205. 17 indexed citations
10.
Ornstein, Deborah L. & Pamela Ely. (1998). Reversible agranulocytosis associated with oral terbinafine for onychomycosis. Journal of the American Academy of Dermatology. 39(6). 1023–1024. 7 indexed citations
11.
Ericson, Solveig G., Kimberly D. Coleman, Kathleen Wardwell, et al.. (1996). Monoclonal antibody 197 (anti‐FcγRI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down‐modulation of FcγRI on circulating monocytes. British Journal of Haematology. 92(3). 718–724. 41 indexed citations
12.
Ely, Pamela, et al.. (1996). Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood. 87(9). 3813–3821. 50 indexed citations
13.
Ericson, Solveig G., et al.. (1995). Mature polymorphonuclear leukocytes express high-affinity receptors for IgG (FcγRI) after stimulation with granulocyte colony-stimulating factor (G-CSF). Journal of Leukocyte Biology. 57(3). 455–461. 47 indexed citations
14.
Ely, Pamela, A. T. Haase, Stephen W. Wietgrefe, et al.. (1992). A new in situ hybridization technique for spliced RNA species documents the bone marrow origin of pulmonary macrophages in chronic myelogenous leukemia. Blood. 80(9). 2321–2325. 1 indexed citations
15.
Ely, Pamela, A. T. Haase, Stephen W. Wietgrefe, et al.. (1992). A new in situ hybridization technique for spliced RNA species documents the bone marrow origin of pulmonary macrophages in chronic myelogenous leukemia. Blood. 80(9). 2321–2325. 4 indexed citations
16.
Ely, Pamela, Jordan Dunitz, John Rogosheske, & Daniel J. Weisdorf. (1991). Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease. The American Journal of Medicine. 90(6). 707–710. 27 indexed citations
17.
Ely, Pamela & Wesley J. Miller. (1991). bcr/abl mRNA DETECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA. Transplantation. 52(6). 1023–1028. 17 indexed citations
18.
Ely, Pamela, Jordan Dunitz, John Rogosheske, & Daniel Weisdorf. (1991). Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease. The American Journal of Medicine. 90(1). 707–710. 7 indexed citations
19.
Ely, Pamela. (1980). The bowel bypass syndrome: A response to bacterial peptidoglycanss. Journal of the American Academy of Dermatology. 2(6). 473–487. 71 indexed citations
20.
Ely, Pamela. (1978). . Archives of Dermatology. 114(6). 968–968. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Berer Breakdown of academic impact, for papers by Diahann T. S. L. Jansen Breakdown of academic impact, for papers by G. W. Löhr Breakdown of academic impact, for papers by B. Sean Carey Breakdown of academic impact, for papers by Annunziata Manna Breakdown of academic impact, for papers by G. J. M. Lafeber Breakdown of academic impact, for papers by G Prentice Breakdown of academic impact, for papers by N. Amos Breakdown of academic impact, for papers by Tommaso Stefanelli Breakdown of academic impact, for papers by S A Bell
Rankless by CCL
2026